Chaker, A. M., Al-Kadah, B., Luther, U., Neumann, U., & Wagenmann, M. (2016). An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: A randomized open label phase II trial. Clin Transl Allergy.
Chicago-stil citatChaker, A. M., B. Al-Kadah, U. Luther, U. Neumann, och M. Wagenmann. "An Accelerated Dose Escalation With a Grass Pollen Allergoid Is Safe and Well-tolerated: A Randomized Open Label Phase II Trial." Clin Transl Allergy 2016.
MLA-referensChaker, A. M., et al. "An Accelerated Dose Escalation With a Grass Pollen Allergoid Is Safe and Well-tolerated: A Randomized Open Label Phase II Trial." Clin Transl Allergy 2016.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.